Inflation Reduction Act Medicare Part D: The $2,100 Cap and What It Means for Your Parent
Inflation Reduction Act Medicare Part D: The $2,100 Cap and What It Means for Your Parent
Starting in 2025, Medicare Part D has an annual out-of-pocket spending cap — something it never had before. Under the Inflation Reduction Act of 2022, beneficiaries' total out-of-pocket costs for covered Part D prescription drugs are capped at $2,000 in 2025 and adjusted to $2,100 in 2026. Once your parent hits the cap, they pay nothing for covered prescriptions for the rest of the year.
For parents on expensive maintenance medications — cancer treatments, biologics, specialty drugs — this cap eliminates the financial catastrophe that used to hit when they reached the old "catastrophic coverage" phase and still owed 5% of drug costs indefinitely.
How the Cap Works
The $2,100 limit counts your parent's actual out-of-pocket spending on covered Part D drugs: deductibles, copayments, and coinsurance. It does not count monthly premiums, drugs purchased outside the plan's formulary, or drugs bought at out-of-network pharmacies (unless the plan covers out-of-network purchases).
Once the $2,100 threshold is met, the Part D plan covers 100% of remaining covered drug costs for the rest of the calendar year. The counter resets on January 1.
Medicare Part D Payment Phases in 2026:
| Phase | What Your Parent Pays |
|---|---|
| Deductible (up to $615) | Full cost of covered drugs |
| Initial coverage | Copayments/coinsurance per the plan's formulary tiers |
| $2,100 cap reached | $0 for covered drugs for the rest of the year |
The old "donut hole" (coverage gap) and catastrophic phase are effectively collapsed by this cap. Your parent never enters a phase where they're paying a percentage of high-cost drugs with no ceiling.
The Medicare Prescription Payment Plan
The Inflation Reduction Act also created an option to spread Part D out-of-pocket costs evenly across the year instead of paying them all at once when prescriptions are filled. Your parent can enroll in the Medicare Prescription Payment Plan through their Part D plan.
Under this option, the plan estimates total annual out-of-pocket drug costs and divides them into equal monthly installments. If your parent takes a $3,000/year specialty drug, instead of paying the full cost in January and February, they'd pay roughly $175/month throughout the year — capped at $2,100 total.
Enrollment is voluntary and can be done at any time during the year. There's no interest or fees. This is particularly useful for parents on fixed incomes who can't absorb a large out-of-pocket hit in the first few months of the year.
What the IRA Changed About Drug Pricing
Beyond the out-of-pocket cap, the Inflation Reduction Act introduced two other provisions that affect what your parent pays:
Insulin cap. Out-of-pocket costs for insulin covered under Part D (and Part B for insulin pumps) are capped at $35 per month per prescription. This applies regardless of whether your parent has reached their deductible.
Vaccine coverage. All vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) are now covered under Part D with no cost-sharing. Before the IRA, some vaccines (like shingles) required significant copayments under Part D.
Drug price negotiation. CMS now negotiates prices directly with manufacturers for selected high-cost drugs. The first round of negotiated prices took effect in 2026 for ten drugs, including treatments for blood cancers, diabetes, heart failure, and blood clots. Future rounds will expand the list.
Free Download
Get the A Caregiver's Guide to Managing a Parent's Medicare — Quick-Start Checklist
Everything in this article as a printable checklist — plus action plans and reference guides you can start using today.
What Caregivers Should Watch For
The $2,100 cap is a genuine improvement, but it's shifted financial risk onto plan sponsors — and they're adapting. Insurers are adjusting Part D plan structures to manage their increased liability:
Narrower formularies. Plans may drop drugs from their formulary or move them to higher cost-sharing tiers to reduce their exposure. During the Annual Election Period, compare your parent's current medication list against next year's formulary carefully.
Expanded prior authorization. More drugs may require prior authorization, step therapy (trying a cheaper drug first), or quantity limits. If your parent's physician prescribes a specific drug, check whether the plan requires prior authorization — and file a formulary exception if a medically necessary drug isn't covered.
Premium increases. Part D premiums may rise as plans absorb more of the cost burden. Compare premiums alongside formulary coverage and pharmacy networks — a plan with a low premium but poor formulary coverage costs more in the long run.
Pharmacy network changes. Some plans are narrowing their preferred pharmacy networks. Verify that your parent's pharmacy is still in-network before the plan year starts.
Annual Plan Review Is More Important Than Ever
The structural changes under the IRA mean that year-over-year plan stability is less reliable. A plan that was ideal in 2025 may have different formulary tiers, different prior authorization requirements, or a different preferred pharmacy network in 2026.
Review your parent's plan during the Annual Election Period every year. The Caregiver's Guide to Managing a Parent's Medicare includes an annual plan review checklist that covers formulary comparison, premium analysis, pharmacy network verification, and the enrollment timeline — so you don't miss the December 7 deadline.
Get Your Free A Caregiver's Guide to Managing a Parent's Medicare — Quick-Start Checklist
Download the A Caregiver's Guide to Managing a Parent's Medicare — Quick-Start Checklist — a printable guide with checklists, scripts, and action plans you can start using today.